13 September 2013 - Deborah Wilkes
Archived
Chile's CFR Pharmaceuticals has agreed to purchase South Africa's Adcock Ingram in a cash and share deal worth ZAR12.6 billion (US$1.30 billion). The news comes two months after the companies revealed they were in discussions.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.